How mission fuels risk-taking, w/Illumina CEO Francis deSouza

Rapid Response

English - August 19, 2021 09:00 - 28 minutes - 26.3 MB - ★★★★★ - 50 ratings
Management Business energy sports news leadership science retail healthcare culture technology startup Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Cultivate an entrepreneurial mindset, w/Reid Hoffman and Sir Richard Branson

Next Episode: How Electronic Arts grows a metaverse, w/CEO Andrew Wilson

Facing off with the FTC isn't for the timid. But when your mission and your business model are aligned, the hard decisions – about risk, about investment, about priorities – become clearer. Francis deSouza is CEO of Illumina, the world’s dominant maker of gene sequencing technology. After playing a key role in the creation of Covid vaccines, Illumina is trying to acquire a company with a breakthrough cancer screening test, over the FTC's objections. DeSouza offers a personal reflection on the lessons and reality of grappling with regulators, highlighting levers that can help to accelerate scale. What underscores his entrepreneurial efforts is a passion for Illumina’s mission: improving human health by unlocking the power of the genome.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.